Training data | Test data | Products | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Full CS1 | CS2 | ExSM | test-CS2 | test-ExSM | dual EPRODS | EPRODS | dual SMKLS | SMKLS | ||
Participants (N) | 2538 | 343 | 343 | 85 | 85 | 82 | 176 | 44 | 198 | |
Age | Mean | 39.5 | 38.8 | 29.5 | 37.1 | 30.0 | 39.0 | 39.2 | 33.4 | 42.2 |
SD | 15.0 | 14.5 | 13.7 | 14.0 | 13.5 | 15.2 | 14.9 | 16.1 | 16.8 | |
Gender (N) | Male | 1217 | 166 | 205 | 40 | 45 | 47 | 74 | - | 187 |
Female | 1321 | 177 | 138 | 45 | 40 | 35 | 102 | - | 11 | |
Ethnicity (N) | White | 1975 | 277 | 236 | 62 | 65 | 71 | 154 | - | 172 |
Black | 329 | 40 | 53 | 13 | 12 | 4 | 11 | - | 11 | |
Other | 234 | 26 | 54 | 10 | 8 | 7 | 11 | - | 15 | |
Alcohol (N)3 | 2280 | 306 | 316 | 78 | 82 | 73 | 165 | 38 | 183 | |
Urban (N)3 | 2263 | 306 | 336 | 71 | 81 | 74 | 167 | 29 | 164 | |
High blood pressure (N)3 | 659 | 80 | 49 | 20 | 6 | 18 | 28 | 11 | 65 | |
High cholesterol (N)3 | 471 | 50 | 50 | 12 | 6 | 11 | 35 | 5 | 47 | |
Diabetes (N)3 | 337 | 50 | 21 | 8 | - | 10 | 17 | - | 26 | |
Cardiovascular disease (N)4 | 272 | 34 | 17 | 10 | 5 | 9 | 13 | - | 16 | |
Respiratory diseases (N)4 | 635 | 100 | 61 | 16 | 14 | 18 | 39 | 6 | 28 | |
FIB (mg/dL) | Mean | 341.5 | 347.5 | 304.6 | 340.0 | 307.8 | 319.0 | 317.6 | 317.6 | 310.4 |
SD | 103.1 | 109.8 | 93.1 | 101.0 | 80.6 | 88.6 | 102.2 | 99.8 | 89.9 | |
hsCRP (mg/L) | Mean | 4.0 | 5.2 | 2.5 | 4.2 | 2.1 | 3.1 | 3.2 | 2.4 | 3.2 |
SD | 7.8 | 10.9 | 4.2 | 7.0 | 3.0 | 4.1 | 5.1 | 3.7 | 6.6 | |
IL6 (pg/mL) | Mean | 2.3 | 2.5 | 1.7 | 2.0 | 1.4 | 2.2 | 1.8 | 2.5 | 2.1 |
SD | 2.1 | 2.4 | 1.8 | 1.9 | 1.4 | 2.3 | 1.8 | 2.7 | 2.0 | |
sICAM (ng/mL) | Mean | 299.0 | 307.4 | 217.3 | 285.7 | 218.9 | 298.6 | 254.5 | 272.0 | 242.0 |
SD | 113.7 | 125.8 | 69.0 | 119.1 | 56.5 | 103.0 | 90.0 | 88.6 | 85.3 | |
8PGFT (ng/g*CRE) | Mean | 688.1 | 682.3 | 391.1 | 605.2 | 417.1 | 680.6 | 541.7 | 560.7 | 485.9 |
SD | 403.4 | 441.2 | 200.9 | 232.7 | 242.4 | 460.9 | 348.3 | 246.7 | 516.0 |